相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Allergy
Adrian Rodriguez-Ferreras et al.
Summary: Kikuchi-Fujimoto Disease (KFD) is a rare disorder characterized by subacute necrotizing regional lymphadenopathy. It has been found that there is a higher number of KFD cases related to COVID-19 vaccines, highlighting the importance of pharmacovigilance in detecting adverse events caused by new vaccines.
EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY
(2023)
Article
Public, Environmental & Occupational Health
Ingrid Oosterhuis et al.
Summary: Due to the large-scale COVID-19 vaccination campaign, the Dutch PV Centre Lareb developed a dedicated system to enable near real-time vaccine safety monitoring. Through automated processing and daily triage, 99.9% of the Individual Case Safety Reports (ICSRs) were processed within the compliance timeframe, and signal detection was performed during the campaign.
Article
Public, Environmental & Occupational Health
Robin E. Ferner et al.
Summary: The data from the study shows that fatal adverse reactions to coronavirus vaccines are rare, but there are cases of CVST and thrombosis associated with the vaccines. Most cases were reported after the reaction had been publicized, and only a minority of cases had thrombocytopenia.
Review
Immunology
Yue Chen et al.
Summary: Autoimmune manifestations have been reported in response to certain COVID-19 vaccines, but it is still unclear whether there is a causal relationship. These reports can help guide the clinical assessment and management of autoimmune manifestations after vaccination.
Article
Rheumatology
Athanasios Sachinidis et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
(2022)
Article
Clinical Neurology
Katarzyna Krzywicka et al.
Summary: This study assessed the age-stratified risk of cerebral venous sinus thrombosis (CVST) with and without thrombocytopenia after SARS-CoV-2 vaccination. The absolute risk of CVST within 28 days of vaccination was highest in the 18-24-year-old age group, and the risk of CVST with thrombocytopenia was slightly increased in patients receiving the Ad26.COV2.S vaccine compared to the estimated background risk. However, there was no increased risk of CVST with thrombocytopenia in recipients of SARS-CoV-2 mRNA vaccines.
Article
Public, Environmental & Occupational Health
Diego Montano
Summary: This study provides a risk assessment of adverse reactions related to COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer-BioNTech. The results show a higher risk of serious adverse reactions for COVID-19 vaccines compared to influenza vaccines, particularly among individuals aged 65 and older.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Clinical Neurology
Anita van de Munckhof et al.
Summary: The mortality of patients with CVST-VITT after vaccination with adenoviral vector-based SARS-CoV-2 vaccines has significantly decreased over time, indicating a potential beneficial effect of early recognition and improved treatment on outcome after VITT.
EUROPEAN JOURNAL OF NEUROLOGY
(2022)
Article
Rheumatology
Luis J. Jara et al.
Summary: Around 60% of the global population has been vaccinated against SARS-CoV-2, leading to a significant reduction in the impact of the pandemic and the resumption of social and economic activities. Studies have shown that the vaccines are effective and safe in various populations, including those with risk factors or immunocompromised individuals. While a minority of people may experience adverse events, including autoimmune syndromes, the exact mechanisms for their development are still being studied. Rheumatologists need to be vigilant in monitoring these autoimmune syndromes and investigating their relationship to vaccination timing.
CLINICAL RHEUMATOLOGY
(2022)
Review
Medicine, General & Internal
Samantha Lane et al.
Summary: Spontaneously reported data from multiple countries were combined to estimate the reporting rate of myocarditis and pericarditis following COVID-19 mRNA vaccines. The analysis showed that younger individuals are more likely to report these adverse events compared to older individuals. The findings were consistent with published literature.
Article
Immunology
Sven H. Loosen et al.
Summary: A study in Germany found that young age, male sex, and pre-existing comorbidities such as dementia, somatoform disorders, anxiety disorders, and depression are associated with vaccine-related adverse events.
Article
Chemistry, Medicinal
Gabriella di Mauro et al.
Summary: This study found an increased reporting frequency of impaired glucose metabolism events, including type 1 and type 2 diabetes, high glucose levels, poor diabetes control, and hypoglycemia, associated with COVID-19 mRNA vaccines compared to viral vector-based vaccines. Further research is warranted to verify these findings.
Article
Immunology
Sophia Hatziantoniou et al.
Summary: This study compares the reporting rates of myocarditis and pericarditis associated with mRNA vaccines between Europe and the United States. The results show that the reporting rates are low, but Europe has more reported cases compared to the United States, and the differences are more pronounced for the mRNA-1273 vaccine.
EXPERT REVIEW OF VACCINES
(2022)
Article
Infectious Diseases
Oliver J. Watson et al.
Summary: A study quantified the global impact of the first year of COVID-19 vaccination programs, finding that the vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. However, inadequate access to vaccines in low-income countries has limited the impact, reinforcing the need for global vaccine equity and coverage.
LANCET INFECTIOUS DISEASES
(2022)
Review
Medicine, General & Internal
Samantha Lane et al.
Summary: The incidence of myocarditis and pericarditis following COVID-19 vaccination is very low, and the benefits of vaccination outweigh the risks. The reporting rates of myocarditis and pericarditis in immunocompromised individuals are similar to the overall population, but with some distinct characteristics.
Article
Immunology
Azam Safary et al.
Summary: Vaccination against COVID-19 is important for achieving herd immunity and controlling the pandemic. However, a small number of people may develop autoimmune rheumatic diseases (ARDs) as a rare adverse reaction to the vaccines. This study identifies individuals who developed de-novo ARDs after COVID-19 vaccination, with a higher prevalence among those who received the AstraZeneca vaccine. Prompt diagnosis and treatment can prevent irreversible organ damage.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Review
Immunology
Yhojan Rodriguez et al.
Summary: This study suggests a potential association between COVID-19 vaccination and autoimmune and inflammatory diseases. New-onset conditions were more common, with immune thrombocytopenia, myocarditis, and Guillain-Barre syndrome being the most common diseases associated with new-onset events. Some diseases may relapse after vaccination. Further large-scale studies are needed to validate this relationship.
JOURNAL OF AUTOIMMUNITY
(2022)
Article
Multidisciplinary Sciences
C. Kedor et al.
Summary: Some COVID-19 patients experience long-lasting symptoms, such as fatigue and exertion intolerance, even after recovery. These symptoms are similar to those seen in non-COVID-19 patients and may be related to low-level inflammation and hypoperfusion.
NATURE COMMUNICATIONS
(2022)
Article
Immunology
Rosanna Ruggiero et al.
Summary: Capillary leak syndrome (CLS), characterized by increased capillary permeability, has been reported as a new adverse event following COVID-19 vaccination. A pharmacovigilance study comparing mRNA vaccines (mRNA-1273 and BNT162b2) and viral vector vaccines (Ad26.COV2-S and ChAdOx1-SARS-COV-2) found a higher occurrence of CLS with viral vector vaccines, particularly Ad26.COV2-S. Women were more affected by CLS, and the outcome was more favorable with mRNA vaccines.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Annamaria Mascolo et al.
Summary: Although the scientific evidence supporting the use of COVID-19 vaccines during pregnancy is limited, this study suggests that the benefits of COVID-19 vaccines during pregnancy outweigh the possible risks. Monitoring the safety profile of COVID-19 vaccines in pregnant women is important.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Cardiac & Cardiovascular Systems
Luigi Cari et al.
Summary: Non-VITT thrombosis can occur in recipients of COVID-19 vaccines, especially those based on adenovirus, at a higher incidence rate compared to VITT. The occurrence of non-VITT thrombosis is influenced by the type of vaccine and the age of the recipients.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Health Care Sciences & Services
Diana Araja et al.
Summary: The COVID-19 pandemic has had a significant impact on global and national developments, affecting various aspects of society and people's lives. This study focuses on the inconsistencies and issues in healthcare revealed by the pandemic, and uses content analysis and statistical analysis to shed light on these problems.
Article
Endocrinology & Metabolism
Montserrat Garcia et al.
Summary: The study found that COVID-19 mRNA vaccines are more frequently associated with reports of subacute thyroiditis compared to other viral vaccines. Well-designed observational studies are needed to confirm these results.
Article
Infectious Diseases
Oliver J. Watson et al.
Summary: The study estimated that COVID-19 vaccination has prevented millions of deaths globally between December 8, 2020, and December 8, 2021. Achieving the vaccination coverage targets set by COVAX and WHO could have prevented even more deaths. However, limited access to vaccines in low-income countries has hindered the impact, highlighting the importance of global vaccine equity.
LANCET INFECTIOUS DISEASES
(2022)
Article
Immunology
Luigi Cari et al.
Summary: The study found that the frequency of severe adverse events in ChAdOx1 nCoV-19 and Ad26.COV2.S vaccine recipients is significantly higher compared to BNT162b2 COVID-19 vaccine recipients, suggesting potential risks associated with virus-based vaccines. However, the frequency of SAE types varies among recipients in different age groups.
JOURNAL OF AUTOIMMUNITY
(2021)
Editorial Material
Medicine, General & Internal
Anthony L. Komaroff et al.
FRONTIERS IN MEDICINE
(2021)
Article
Public, Environmental & Occupational Health
Chongliang Luo et al.
Summary: This study developed prediction models for Guillain-Barre syndrome (GBS) using data from the US Vaccine Adverse Event Reporting System (VAERS), identifying highly associated adverse events with GBS and excluding likely underreported common and mild adverse events to improve the models' interpretability and feasibility. The prediction performance demonstrated the potential of risk-prediction models utilizing the VAERS cohort, with a high absolute risk of GBS suggested even with a small number of adverse event combinations.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
(2021)
Article
Hematology
Jonathan Douxfils et al.
Summary: While the reported cases of thromboembolic events post-vaccination with AstraZeneca vaccine were lower than estimated rates in the general population, the European Medicines Agency concluded that there may be a very rare side effect of unusual thromboses with low blood platelets associated with the vaccine. Further investigations are needed to understand the potential relationship between vaccination and these rare events.
THROMBOSIS RESEARCH
(2021)
Article
Immunology
Miguel Garcia-Grimshaw et al.
Summary: mRNA vaccines against SARS-CoV-2 are shown to be safe and effective, with low incidence of adverse events post-immunization, most of which are non-serious, with neurologic AEFIs being the majority. The vaccines offer significant individual and societal benefits, outweighing the low percentage of serious neurologic AEFIs, which should help dispel hesitancy towards this new vaccine platform.
CLINICAL IMMUNOLOGY
(2021)
Article
Clinical Neurology
Katarzyna Krzywicka et al.
Summary: This study analyzed 213 cases of CVST after COVID-19 vaccination, with distinct clinical profiles between recipients of AstraZeneca/Oxford and mRNA vaccines, including differences in thrombocytopenia and mortality rates.
EUROPEAN JOURNAL OF NEUROLOGY
(2021)
Article
Immunology
Luigi Cari et al.
Summary: The study compared the frequency of severe adverse events (SAEs) between ChAdOx1 nCoV-19 Covid-19 and BNT162b2 Covid-19 vaccines in Europe, showing that recipients of ChA vaccine have higher risks in bleeding, thrombocytopenia, and blood clots. Young people and women of reproductive age may be at higher risk following ChA vaccination.
JOURNAL OF AUTOIMMUNITY
(2021)
Article
Neurosciences
Elisa Mantovani et al.
Summary: The study found that 27% of SARS-CoV-2 survivors exhibit symptoms resembling ME/CFS, with these individuals showing worse sleep quality, fatigue, pain, depressive symptoms, and cognitive complaints. This raises concerns about a potential future pandemic of ME/CFS-like symptoms in SARS-CoV-2 survivors.
JOURNAL OF NEUROVIROLOGY
(2021)
Article
Hematology
Maria Abbattista et al.
Summary: This study assessed the reporting rate of cerebral vein thrombosis (CVT) as an adverse drug reaction for four COVID-19 vaccines authorized in Europe. The results showed that all four vaccines were associated with CVT and thrombocytopenia.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
(2021)
Review
Biochemistry & Molecular Biology
Anthony L. Komaroff et al.
Summary: SARS-CoV-2 infection can lead to chronic and acute diseases, with postacute sequelae including potential organ damage and symptoms, as well as a post-COVID19 syndrome called 'long COVID' resembling ME/CFS symptoms.
TRENDS IN MOLECULAR MEDICINE
(2021)
Article
Biotechnology & Applied Microbiology
Michele Gringeri et al.
Summary: The first available vaccine against SARS-CoV-2 in Italy is the two-dose mRNA-based vaccine BNT162b2 developed by Pfizer-BioNTech. Over 2000 healthcare professionals at the Fatebenefratelli-Sacco hospital have received both doses. By analyzing spontaneous safety reports and comparing them to those submitted in EudraVigilance and clinical trials, several new and unexpected adverse reactions have been identified, which will be useful for reviewing the safety profile of this vaccine.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Medicine, General & Internal
Diana Araja et al.
Summary: ME/CFS is a complex disorder with severe fatigue and other symptoms, causing substantial reductions in functional activity and quality of life. The study investigates undiagnosed ME/CFS patients, with a focus on potential post-viral CFS as a consequence of COVID-19. Results show that former COVID-19 patients report more anxiety and fatigue symptoms compared to ME/CFS patients and undiagnosed patients.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Clinical Neurology
Shitiz Sriwastava et al.
Summary: This paper extensively reviewed neurological complications following COVID-19 vaccination, emphasizing the importance of neuroimaging for diagnosing adverse effects post-COVID-19 vaccination.
NEUROLOGY INTERNATIONAL
(2021)
Article
Medicine, General & Internal
Elenka Brenna et al.
Summary: There were similarities in demographic features, impact of illness on household incomes, and quality of life among patients in the three countries, but significant differences were found in illness progression and management, reflecting variations in healthcare patterns and societal attitudes.
MEDICINA-LITHUANIA
(2021)
Review
Pharmacology & Pharmacy
Joanne Potts et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2020)
Article
Public, Environmental & Occupational Health
Rodrigo Postigo et al.
Article
Computer Science, Information Systems
Wei Shang et al.
ONLINE INFORMATION REVIEW
(2017)
Article
Public, Environmental & Occupational Health
Aniello Santoro et al.
Article
Computer Science, Interdisciplinary Applications
Ming Yang et al.
JOURNAL OF BIOMEDICAL INFORMATICS
(2015)
Article
Public, Environmental & Occupational Health
Luis Prieto et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
(2012)
